Medicaid

Georgia Medicare Annual Depression Screening 2026 Guide

Medicare covers annual depression screening for all beneficiaries through National Coverage Determination (NCD) 210.9, established under Section 1861(ddd) preventive services authority.

Brevy Care Team

· 32 min read

By Brevy Care Team

Medicare covers annual depression screening for all beneficiaries through National Coverage Determination (NCD) 210.9, established under Section 1861(ddd) preventive services authority. The benefit became effective October 14, 2011 following the USPSTF Grade B recommendation for depression screening in adults. The screening must be performed in a primary care setting that has staff-assisted depression care supports in place to ensure accurate diagnosis, effective treatment, and follow-up. ACA Section 4104 applies the preventive services cost-sharing waiver, making annual depression screening free for Medicare beneficiaries.

For Georgia Medicare beneficiaries, depression screening is a critically important preventive service. Late-life depression is common, with major depression affecting approximately 1 to 5 percent of community-dwelling older adults and subsyndromal depression affecting an additional 10 to 15 percent. Depression in older adults is frequently undiagnosed and undertreated. It is associated with increased mortality from suicide, cardiovascular disease, and other causes. Older men in particular face elevated suicide risk, with the highest suicide rates of any demographic group in the United States found among non-Hispanic white men age 75 and older. Annual depression screening through primary care is a structured opportunity to identify depression and connect beneficiaries with effective treatment. This guide explains the statutory framework, the staff-assisted depression care supports requirement, standardized screening tools used in primary care, HCPCS coding, cost-sharing under the ACA Section 4104 waiver, the relationship between standalone depression screening and the Annual Wellness Visit's required depression screening element, coordination with pharmacotherapy and psychotherapy treatment, behavioral health referral pathways, suicide risk considerations, and the Georgia behavioral health landscape.

Key Takeaways

Statutory authority: Section 1861(ddd) of the Social Security Act provides the preventive services authority allowing CMS to add coverage for additional preventive services with USPSTF Grade A or B recommendations. Annual depression screening was added through NCD 210.9 effective October 14, 2011.
Annual frequency: Medicare covers depression screening once per 12-month period. The 12-month interval is based on the calendar date of the prior screening.
Primary care setting requirement: NCD 210.9 requires that the screening be performed in a primary care setting that has staff-assisted depression care supports in place. This is the most distinctive coverage requirement and reflects the underlying USPSTF evidence base showing that depression screening is most effective when integrated with depression care.
Staff-assisted depression care supports: The primary care setting must have staff capacity (e.g., case manager, care coordinator, nurse, or other staff) to assist the primary care clinician in (a) supporting accurate diagnosis, (b) facilitating effective treatment (including pharmacotherapy, psychotherapy, or referral), and (c) following up.
HCPCS coding: Annual depression screening is billed under HCPCS G0444 (annual depression screening, 15 minutes). The 15-minute time element is part of the code definition.
ACA cost-sharing waiver: ACA Section 4104 eliminates Part B deductible and coinsurance for USPSTF Grade A and B preventive services. Annual depression screening is $0 for beneficiaries when furnished according to NCD 210.9 requirements.
Standardized screening tools: The Patient Health Questionnaire (PHQ-2 and PHQ-9), the Geriatric Depression Scale (GDS), and other validated tools may be used. PHQ-2 is a 2-item screen often used initially; positive PHQ-2 triggers full PHQ-9 assessment.
AWV coordination: The Annual Wellness Visit (Section 1861(hhh)) includes depression screening as one of its required health risk assessment elements. The standalone annual depression screening (G0444) may be furnished on the same day as the AWV with appropriate modifier use, or on a separate date.
Older adult depression and suicide risk: Late-life depression is common and frequently undiagnosed. Older adults face the highest suicide rates of any age group, particularly older non-Hispanic white men. Annual depression screening is a critical opportunity for identification and intervention.
Georgia behavioral health landscape: Major Georgia behavioral health programs include Skyland Trail, Ridgeview Institute, Peachford Hospital, Emory Behavioral Health, Wellstar Behavioral Health, and the network of Community Service Boards. The Georgia Crisis and Access Line (1-800-715-4225) and the 988 Suicide and Crisis Lifeline provide 24/7 crisis support.

Part 1: The Statutory and Regulatory Framework

Section 1861(ddd) Preventive Services Authority

Section 1861(ddd) of the Social Security Act provides CMS authority to add Medicare coverage for "additional preventive services" beyond those specifically enumerated in the statute. The service must be:

Reasonable and necessary for the prevention or early detection of illness or disability.
Recommended with a grade of A or B by the USPSTF.
Appropriate for individuals entitled to benefits under Part A or enrolled under Part B.

Annual depression screening qualifies under this framework because the USPSTF recommends depression screening with Grade B for the general adult population, and screening is appropriate for the Medicare population given the substantial late-life depression burden.

National Coverage Determination 210.9

CMS issued National Coverage Determination 210.9 effective October 14, 2011 to add Medicare coverage for annual depression screening in the primary care setting. NCD 210.9 specifies:

Annual frequency (once per 12-month period).
Primary care setting requirement.
Staff-assisted depression care supports requirement.
Coverage for all Medicare beneficiaries (no specific eligibility limitations beyond the primary care setting requirement).

The NCD reflects the underlying USPSTF evidence base, which concludes that depression screening is most effective when integrated with depression care that supports accurate diagnosis, evidence-based treatment, and adequate follow-up.

The Primary Care Setting Requirement

NCD 210.9 explicitly limits coverage to depression screening performed in a "primary care setting." The NCD defines this as the principal location where a beneficiary receives primary care services. Primary care settings include:

Family medicine practices.
Internal medicine practices.
General practice clinics.
Geriatric medicine practices.
Federally Qualified Health Centers (FQHCs).
Rural Health Clinics (RHCs).

Settings explicitly excluded from coverage under NCD 210.9 include:

Emergency departments.
Inpatient hospital settings.
Skilled nursing facilities.
Independent ambulatory surgical centers (when not in a primary care role).
Hospice care settings.

This restriction reflects the underlying evidence that depression screening produces benefit only when integrated with primary care infrastructure capable of following through with diagnosis and treatment.

Staff-Assisted Depression Care Supports

The most distinctive coverage requirement under NCD 210.9 is that the primary care setting must have "staff-assisted depression care supports" in place. CMS describes this as having clinical staff (such as nurses, social workers, case managers, or other staff) who, in addition to the primary care clinician, can support:

Accurate diagnosis — for example, by administering and scoring standardized depression assessment tools, gathering collateral history, and supporting the diagnostic workup beyond a standard primary care encounter.
Effective treatment — for example, by facilitating medication initiation and follow-up, coordinating referral to psychotherapy or psychiatry, and supporting adherence.
Follow-up — for example, by tracking symptom response over time, ensuring follow-up appointments, and re-administering standardized tools to assess treatment response.

This requirement is intended to ensure that depression screening does not produce false-positive labeling or untreated depression diagnoses but rather connects beneficiaries with effective care.

42 CFR 410.64 Implementing Regulations

The implementing regulations at 42 CFR 410.64 establish Medicare coverage of "additional preventive services" added through the Section 1861(ddd) framework. Annual depression screening operates under this regulatory framework. Service-specific coverage details flow from NCD 210.9 itself.

ACA Section 4104 (Public Law 111-148) eliminates Part B deductible and coinsurance for USPSTF Grade A or B preventive services effective January 1, 2011. Depression screening received USPSTF Grade B in 2009 and re-affirmed Grade B in subsequent updates. Beneficiaries pay $0 for annual depression screening when furnished according to NCD 210.9 requirements.

Part 2: Eligibility

Universal Adult Eligibility

NCD 210.9 does not specify eligibility criteria beyond the requirement that the screening be performed in a primary care setting with staff-assisted depression care supports. All Medicare Part B beneficiaries are eligible for annual depression screening.

Frequency Limitation

The benefit allows one depression screening per 12-month period per beneficiary. The 12-month interval is calculated from the calendar date of the prior screening, not from the calendar year boundary. A beneficiary screened in March of one year becomes eligible for a subsequent screening on or after the same March date the following year.

Coordination With AWV

The Annual Wellness Visit (AWV) under Section 1861(hhh) includes depression screening as part of its required health risk assessment elements. CMS allows separate billing of the standalone annual depression screening (G0444) on the same encounter as the AWV when both services are clearly documented as separate activities, generally with an appropriate modifier. Alternatively, the depression screening component embedded in the AWV may satisfy the year's screening, and a separate G0444 claim may not be billed in the same 12-month period.

In practice, primary care practices vary in their approach:

Some bill the AWV alone, considering the embedded depression screening sufficient.
Some bill the AWV plus G0444 when more extensive depression assessment occurs.
Some schedule the AWV and a separate depression screening encounter at different visits.

Each approach can be appropriate depending on practice workflow and the clinical situation.

Part 3: HCPCS Coding

HCPCS G0444 — Annual Depression Screening, 15 Minutes

HCPCS G0444 is the specific code for the standalone annual depression screening benefit under NCD 210.9. The code definition includes a 15-minute time element, reflecting the time investment expected for a comprehensive screening that includes:

Administering the standardized screening tool.
Scoring and interpreting results.
Reviewing positive screens with the beneficiary.
Discussing next steps if the screen is positive.
Documenting the screening result in the medical record.

The 15-minute time element distinguishes the depression screening from a brief screen that might occur as part of a routine clinical encounter.

Modifier Use for Same-Day AWV

When the annual depression screening is performed at the same encounter as the Annual Wellness Visit (HCPCS G0438 initial AWV or G0439 subsequent AWV), Medicare typically requires modifier use (commonly modifier 25) to indicate that the depression screening is a separately identifiable service. Practice billing staff should confirm modifier conventions with the Medicare Administrative Contractor (Palmetto GBA for Georgia).

Diagnostic Coding

Annual depression screening is typically submitted with a diagnosis code for screening (e.g., Z13.31 encounter for screening examination for depression, Z13.89 encounter for screening for other disorder). Positive screens leading to a depression diagnosis are then coded with the appropriate clinical diagnosis (e.g., F32 series for major depressive disorder).

ACA Section 4104 waives Part B deductible and coinsurance for USPSTF Grade A or B aligned preventive services. Depression screening received Grade B for adults from USPSTF, and the screening is $0 for beneficiaries when furnished according to NCD 210.9 requirements.

Subsequent Diagnostic and Treatment Services

If the annual depression screening identifies positive findings warranting clinical evaluation or treatment, subsequent services are subject to standard Part B cost-sharing. These include:

Diagnostic evaluation for depression (E/M visits coded with appropriate level).
Initial psychiatric evaluation by a psychiatrist or other qualified mental health professional.
Psychotherapy sessions (individual, group, family).
Medication management visits.
Behavioral health integration services (under the Collaborative Care Model HCPCS codes G0512, 99492, 99493, 99494).

Beneficiaries with Medicare Supplement (Medigap) insurance may have all or most of these cost-sharing amounts covered through their supplement. Dually eligible beneficiaries have Medicaid as secondary payer for Part B cost-sharing.

Mental Health Parity

The Mental Health Parity and Addiction Equity Act of 2008 generally requires that mental health benefits be provided on the same basis as medical/surgical benefits. For Medicare Part B services, this means that cost-sharing for mental health services is generally the same as for other Part B services (typically 20 percent coinsurance after the deductible). Historical limitations on Medicare outpatient mental health coverage (e.g., the prior 50 percent coinsurance rate for psychotherapy) have been eliminated through phased Mental Health Parity implementation.

Part 5: Standardized Screening Tools

Patient Health Questionnaire — PHQ-2 and PHQ-9

The Patient Health Questionnaire is the most commonly used depression screening instrument in primary care settings. It has two main versions:

PHQ-2: A 2-item screening tool asking about depressed mood and anhedonia over the past 2 weeks. Scored 0 to 6. A score of 3 or higher is considered positive and triggers full PHQ-9 administration.
PHQ-9: A 9-item screening and severity assessment tool addressing the nine DSM criteria for major depressive disorder over the past 2 weeks. Scored 0 to 27. Severity bands typically used: 0 to 4 minimal, 5 to 9 mild, 10 to 14 moderate, 15 to 19 moderately severe, 20 to 27 severe.

The PHQ-9 also includes Question 9 about thoughts of self-harm or suicidal ideation, which warrants immediate clinical attention when endorsed.

Geriatric Depression Scale (GDS)

The Geriatric Depression Scale was specifically designed for older adults and avoids somatic symptoms that may be confounded by medical comorbidity. The GDS has long-form (30-item), short-form (15-item), and ultra-short-form (5-item or 1-item) versions:

GDS-15: Most commonly used version in clinical practice. Yes/no responses. Scored 0 to 15. Cutoffs typically: 0 to 4 no depression, 5 to 9 mild depression, 10 to 15 moderate to severe depression.

The GDS may be particularly suitable for older adults with significant medical comorbidities where somatic symptoms (fatigue, sleep changes, appetite changes) on the PHQ-9 may not reliably indicate depression.

Other Validated Tools

Additional validated depression screening tools include the Center for Epidemiologic Studies Depression Scale (CES-D), the Beck Depression Inventory (BDI), the Hamilton Depression Rating Scale (clinician-administered), and the Cornell Scale for Depression in Dementia (specifically for dementia patients).

For the Medicare NCD 210.9 benefit, the specific tool is not prescribed; primary care practices choose validated tools appropriate to their patient population and workflow.

Modifications for Cognitive Impairment

Beneficiaries with significant cognitive impairment (moderate to severe dementia) may have difficulty completing self-report screening tools. The Cornell Scale for Depression in Dementia is a clinician-administered tool that incorporates information from caregivers and clinical observation. The Geriatric Depression Scale may be administered with caregiver assistance for mild cognitive impairment.

Part 6: Coordination With Treatment

Pharmacotherapy

For beneficiaries with positive depression screens leading to a clinical depression diagnosis, pharmacotherapy is a primary treatment option. Medicare Part D covers antidepressant medications including:

Selective serotonin reuptake inhibitors (SSRIs): sertraline, escitalopram, citalopram, fluoxetine, paroxetine.
Serotonin-norepinephrine reuptake inhibitors (SNRIs): duloxetine, venlafaxine.
Atypical antidepressants: mirtazapine, bupropion.
Tricyclic antidepressants (TCAs): nortriptyline, desipramine, doxepin (used cautiously in older adults due to anticholinergic and cardiac effects).
Other: trazodone, vilazodone, vortioxetine.

For older adults, SSRIs are generally first-line due to favorable side effect profile. Tricyclic antidepressants are typically avoided in older adults due to anticholinergic burden and cardiac risks.

Medication management is provided through follow-up visits with the primary care clinician or psychiatry, with cost-sharing applied as standard Part B.

Psychotherapy

Medicare Part B covers individual psychotherapy (CPT 90832, 90834, 90837), family psychotherapy (CPT 90846, 90847), and group psychotherapy (CPT 90853). Covered providers include:

Psychiatrists (MD/DO).
Psychologists (PhD/PsyD).
Clinical social workers (LCSW).
Marriage and family therapists (Medicare expanded coverage to MFTs effective January 1, 2024).
Mental health counselors (Medicare expanded coverage to MHCs effective January 1, 2024).
Clinical nurse specialists and nurse practitioners with mental health scope.

The expansion of Medicare-covered mental health providers to include MFTs and MHCs (effective January 1, 2024, per Consolidated Appropriations Act 2023) substantially expanded provider supply, particularly in rural and underserved areas.

Behavioral Health Integration (Collaborative Care Model)

Medicare covers behavioral health integration services delivered through the Collaborative Care Model (CoCM). CoCM uses HCPCS codes:

G0512 (RHC/FQHC behavioral health integration).
99492 (Initial month CoCM, 70+ minutes).
99493 (Subsequent months CoCM, 60+ minutes).
99494 (CoCM add-on, additional 30 minutes).

CoCM involves a primary care clinician working with a behavioral health care manager and a psychiatric consultant to deliver depression and other behavioral health care within primary care. The model has strong evidence for effectiveness in depression treatment.

Crisis Intervention

For beneficiaries with positive screens that reveal suicidal ideation or imminent risk, immediate intervention is essential. The 988 Suicide and Crisis Lifeline (effective July 16, 2022 nationally as the streamlined three-digit number replacing the prior 1-800-273-TALK number) provides 24/7 crisis support. The Georgia Crisis and Access Line (1-800-715-4225) provides state-specific crisis support and mobile crisis response. Emergency department evaluation may be necessary for imminent risk.

Part 7: Older Adult Depression Epidemiology and Suicide Risk

Late-Life Depression Prevalence

Depression in older adults is common but frequently underdiagnosed:

Major depressive disorder: approximately 1 to 5 percent of community-dwelling older adults.
Subsyndromal depressive symptoms: approximately 10 to 15 percent of community-dwelling older adults.
Major depression in primary care settings: approximately 5 to 10 percent.
Major depression in nursing home residents: approximately 14 to 42 percent.
Major depression in medically ill older adults: approximately 10 to 12 percent in general medical inpatient populations.

Late-life depression is associated with substantial morbidity including functional decline, cognitive impairment, increased medical comorbidity, increased healthcare utilization, and increased mortality.

Suicide Risk in Older Adults

Older adults face elevated suicide risk, with the highest age-specific suicide rates of any age group in the United States found in non-Hispanic white men age 75 and older. Key features of late-life suicide:

Suicide attempts in older adults are more often lethal than in younger adults.
The ratio of attempts to completions is approximately 4:1 in older adults compared to approximately 200:1 in adolescents.
Older men account for the substantial majority of late-life suicides.
Common risk factors include depression, social isolation, recent loss (spouse, health, function), medical illness, and access to firearms.
Recent contact with a primary care clinician is common before suicide; approximately 70 percent of older adults who die by suicide had seen their primary care clinician within the prior 30 days.

This last finding underscores the critical importance of primary care depression screening for older adults.

Suicide Risk Considerations in Screening

PHQ-9 Question 9 ("Thoughts that you would be better off dead or of hurting yourself in some way") triggers further clinical evaluation when endorsed. Clinical evaluation should include:

Assessment of intent (passive thoughts vs. active ideation).
Assessment of plan (specificity of method).
Assessment of means (access to firearms, medications).
Assessment of timeline.
Identification of protective factors.
Determination of imminent risk.

Imminent suicide risk warrants emergency department evaluation. Non-imminent active suicidal ideation warrants urgent psychiatric evaluation. Passive suicidal ideation warrants close clinical follow-up and treatment.

Late-Life Depression Treatment Effectiveness

Late-life depression is treatable. Evidence supports:

SSRIs and SNRIs as first-line pharmacotherapy.
Cognitive behavioral therapy (CBT).
Interpersonal therapy (IPT).
Problem-solving therapy.
Behavioral activation.
Collaborative care models in primary care.
Electroconvulsive therapy for severe or treatment-resistant cases.

Response rates with appropriate treatment are similar to those in younger adults.

Part 8: Coordination With AWV and IPPE

AWV Required Depression Screening Element

The Annual Wellness Visit under Section 1861(hhh) includes depression screening as one of its required health risk assessment elements. The AWV requires identification of risk factors for depression including current and prior history. The depression screening within the AWV typically uses a brief tool such as PHQ-2.

A practice has options for how to handle annual depression screening:

Bill AWV alone: The embedded depression screening element in the AWV may serve as the year's depression screening, and no separate G0444 claim is submitted.
Bill AWV plus G0444: When more comprehensive depression assessment occurs (e.g., full PHQ-9 administration with scoring documentation, discussion of results, treatment planning), the G0444 may be billed in addition to the AWV with modifier 25.
Schedule separate visits: The AWV and a dedicated depression screening encounter may occur at different visits during the year.

IPPE Coordination

The Initial Preventive Physical Examination under Section 1861(ww), the "Welcome to Medicare" visit, is available within the first 12 months of Medicare Part B enrollment. The IPPE includes a review of risk factors for depression. While the IPPE itself is a one-time benefit, depression risk identification during the IPPE supports referral to subsequent annual depression screening through NCD 210.9.

Practice Workflow Integration

Many primary care practices integrate depression screening into their AWV workflow, with medical assistants or other staff administering PHQ-2 (or PHQ-9 for positive PHQ-2) before the clinician encounter. Positive screens trigger clinician review and discussion. This workflow operationalizes both the AWV depression screening element and the staff-assisted depression care supports requirement of NCD 210.9.

Part 9: The Georgia Behavioral Health Landscape

Major Georgia Inpatient and Residential Behavioral Health Programs

Skyland Trail

Skyland Trail (Atlanta) provides intensive outpatient and residential mental health treatment for adults with mood disorders, anxiety disorders, schizophrenia, and dual diagnosis. Skyland Trail's older adult programming addresses late-life depression and cognitive issues.

Phone: 404-315-8333.

Ridgeview Institute

Ridgeview Institute (Smyrna, Cobb County) provides inpatient psychiatric care, partial hospitalization, intensive outpatient, and substance abuse treatment. Programs include older adult psychiatric services.

Phone: 770-434-4567.

Peachford Hospital

Peachford Hospital (Atlanta/Dunwoody) provides inpatient psychiatric and addiction treatment. Programs include the Senior Care Program for older adults with psychiatric needs.

Phone: 770-455-3200.

Emory Behavioral Health

Emory Healthcare operates comprehensive behavioral health services including inpatient psychiatry at Emory University Hospital and Emory Wesley Woods Hospital, outpatient psychiatry, geriatric psychiatry, and behavioral health integration in primary care.

Wellstar Behavioral Health

Wellstar Health System operates inpatient psychiatry and outpatient behavioral health services across north and west Georgia.

Piedmont Behavioral Health

Piedmont Healthcare operates inpatient psychiatry and outpatient behavioral health services across metro Atlanta and Georgia regions.

Community Service Boards

Georgia's Community Service Boards (CSBs) provide publicly funded mental health, developmental disability, and substance abuse services. CSBs operate across all Georgia counties, organized into 25 regional service areas. CSB services are particularly important for low-income beneficiaries and beneficiaries without private behavioral health access. CSBs accept Medicare and Medicaid in addition to providing services on a sliding fee scale.

Georgia Crisis and Access Line

The Georgia Crisis and Access Line (GCAL) is operated by the Georgia Department of Behavioral Health and Developmental Disabilities. GCAL provides 24/7 crisis intervention, mobile crisis response, behavioral health information and referral, and care coordination.

Phone: 1-800-715-4225.

988 Suicide and Crisis Lifeline

The 988 Suicide and Crisis Lifeline became operational July 16, 2022 as the streamlined three-digit number for suicide and mental health crisis support, replacing the prior 1-800-273-TALK (8255) number. 988 provides 24/7 crisis support nationwide with state-specific routing to local crisis services.

Federally Qualified Health Centers

FQHCs across Georgia provide integrated primary care and behavioral health services for medically underserved populations. FQHCs are particularly important for rural Georgia depression screening and treatment access, given the lower availability of private behavioral health providers in many rural counties.

Rural Behavioral Health Access Considerations

Rural Georgia counties face substantial behavioral health workforce shortages. The Georgia Health Professional Shortage Area designations include many rural counties for mental health professional shortage. Telebehavioral health expansion (including Medicare coverage of audio-only behavioral health services for many indications) has expanded rural beneficiary access to mental health care.

Part 10: Best Practices for Beneficiaries and Clinicians

Integrate depression screening into AWV workflow: Capture depression screening during the AWV using standardized tools (PHQ-2 with PHQ-9 follow-up for positives or GDS-15) administered by staff before the clinician encounter.
Ensure staff-assisted depression care supports are in place: NCD 210.9 requires the primary care setting to have staff capacity for diagnosis support, treatment facilitation, and follow-up. Practices billing G0444 should verify they have this infrastructure.
Use validated screening tools: PHQ-2, PHQ-9, GDS-15, and other validated tools are appropriate. Choose the tool best suited to the patient population and workflow.
Address PHQ-9 Question 9 directly: Any endorsement of thoughts of self-harm or suicidal ideation requires immediate clinical evaluation. Have a workflow protocol in place for positive Question 9.
Document the screening tool, score, and follow-up plan: Documentation supports the G0444 claim and demonstrates compliance with the NCD 210.9 staff-assisted depression care supports requirement.
Differentiate AWV depression screening from G0444: When billing G0444 in addition to the AWV, ensure documentation reflects a separately identifiable, more extensive depression assessment beyond the AWV's required element.
Initiate treatment promptly for positive screens: Pharmacotherapy, psychotherapy, or behavioral health integration should be initiated promptly when a positive screen leads to a depression diagnosis. Delays in treatment initiation may diminish the value of screening.
Use the Collaborative Care Model: The CoCM (HCPCS G0512, 99492, 99493, 99494) has strong evidence for depression treatment in primary care. Practices able to implement CoCM should consider it for depression care.
Coordinate with psychiatry for complex cases: Treatment-resistant depression, severe depression, suicidal ideation, complex pharmacotherapy decisions, and cases involving bipolar disorder warrant psychiatric referral.
Leverage 988 and the Georgia Crisis and Access Line: For positive screens revealing crisis-level concerns, immediate connection to 988 (Suicide and Crisis Lifeline) or 1-800-715-4225 (Georgia Crisis and Access Line) provides 24/7 crisis support.
Address social determinants of depression: Late-life depression often coexists with social isolation, bereavement, caregiving stress, financial concerns, and functional decline. Address these factors through care coordination and community resource referral.
Use the expanded Medicare mental health provider list: Effective January 1, 2024, Medicare covers Marriage and Family Therapists and Mental Health Counselors in addition to previously covered providers. This expansion is particularly valuable for rural beneficiary access.
Recognize and respond to suicide risk in older men: Older non-Hispanic white men have the highest suicide rates of any demographic group. Be especially attentive to depression screening, social isolation, recent loss, firearm access, and functional decline in this population.
Reassess at appropriate intervals: Annual screening is the minimum frequency; clinical context may warrant more frequent reassessment, particularly during medication changes, life transitions, or after recent significant losses.

Part 11: Common Issues and Resolutions

The depression screening claim was denied for primary care setting requirement: NCD 210.9 limits coverage to depression screening in primary care settings. Claims from emergency departments, inpatient hospital settings, skilled nursing facilities, or other excluded settings will be denied. The screening must be performed at a primary care practice (family medicine, internal medicine, geriatric medicine, FQHC, RHC, or similar).
The screening was denied because staff-assisted depression care supports were not documented: NCD 210.9 requires the practice to have staff-assisted depression care supports in place. The Medicare Administrative Contractor may require documentation of practice infrastructure on audit. Maintain documentation of staffing model and depression care workflow.
A beneficiary received depression screening 10 months ago and a repeat is being requested: The 12-month frequency limitation requires that 12 months have passed since the prior depression screening before a subsequent G0444 claim is eligible. Earlier follow-up depression assessment may be billed as a diagnostic E/M service.
G0444 was denied when billed with AWV: Same-day billing of G0444 with AWV (G0438 or G0439) requires appropriate modifier use (typically modifier 25) to indicate separately identifiable services. Confirm modifier conventions with Palmetto GBA.
The screening tool used is not validated for older adults: While NCD 210.9 does not prescribe specific tools, using a validated tool appropriate for the patient population is important. PHQ-9 and GDS-15 are both well-validated for older adults. Consider GDS-15 when somatic confounders are prominent.
A positive screen reveals suicidal ideation but no behavioral health provider is available locally: Initial response includes safety assessment (intent, plan, means, timeline), connection to 988 or the Georgia Crisis and Access Line for immediate support, consideration of emergency department referral for imminent risk, and follow-up through primary care or telebehavioral health for ongoing care.
The beneficiary has cognitive impairment and cannot complete PHQ-9 self-report: For beneficiaries with significant cognitive impairment, the Cornell Scale for Depression in Dementia is a clinician-administered tool that incorporates caregiver input and clinical observation. Adapt screening to the beneficiary's capacity.
The beneficiary has positive screen but declines treatment: Beneficiaries have the right to decline recommended treatment after informed discussion. Document the discussion, the recommendation, the beneficiary's decision, and the plan for ongoing monitoring. Continued primary care follow-up with periodic reassessment is appropriate.
The beneficiary is dually eligible with Medicaid managed care behavioral health carve-out: For dually eligible beneficiaries enrolled in Georgia Medicaid managed care, behavioral health services may be carved out to a separate Medicaid behavioral health vendor. Coordinate with both Medicare and Medicaid plan structures.
A beneficiary in Medicare Advantage has limited in-network behavioral health providers: Medicare Advantage plans must cover behavioral health services at least as comprehensively as Original Medicare. Network adequacy concerns can be raised with the plan and, if unresolved, with CMS and the Georgia Department of Insurance.
The cost-sharing for follow-up psychotherapy is a barrier: Standard Part B cost-sharing (20 percent coinsurance after deductible) applies to psychotherapy. Medicare Supplement insurance, dual Medicaid eligibility, and patient assistance programs may help. The Collaborative Care Model and FQHC sliding fee scales may also reduce financial barriers.
Telehealth versus in-person depression screening: Medicare coverage of telehealth for behavioral health services expanded substantially during and after the public health emergency. Audio-only behavioral health services are covered for many indications. Confirm specific telehealth coverage with Palmetto GBA.
The Beneficiary's screening tool result is not clearly positive but the beneficiary reports significant distress: Clinical judgment supplements screening tools. A beneficiary reporting significant distress despite a screening tool not meeting positive thresholds warrants further clinical evaluation.
Coordination of antidepressant management between primary care and psychiatry: Communication between primary care and psychiatry is essential for medication management. Establish clear documentation of responsibility for monitoring response and side effects, frequency of follow-up, and management of suicide risk during treatment initiation.

Part 12: Worked Examples

Example 1: Fulton County Age 70 Female Annual Depression Screening During AWV Positive PHQ-9

A 70-year-old woman living in Fulton County (Atlanta), enrolled in Original Medicare Part B for five years, comes to her Emory primary care practice for her Annual Wellness Visit. The practice has a depression screening workflow in which medical assistants administer PHQ-2 before the clinician encounter; positive PHQ-2 triggers PHQ-9 administration. The patient's PHQ-2 is 5 (positive). She completes the PHQ-9 with a score of 14 (moderate depression). She endorses persistent sadness, anhedonia, sleep disturbance, fatigue, feelings of worthlessness, and concentration difficulty since her husband's death from cancer six months earlier. PHQ-9 Question 9 is endorsed at a level of "several days" with passive thoughts ("I sometimes feel I'd be better off dead") but no active suicidal ideation, plan, or intent.

The primary care physician conducts a structured depression assessment beyond the AWV's required screening element, including safety assessment for the passive suicidal ideation. The physician determines that the beneficiary has moderate major depression following her husband's death, without imminent suicide risk. Treatment recommendations include initiation of sertraline 25 mg daily (with planned titration), referral to grief-focused individual psychotherapy at an Emory-affiliated behavioral health practice (LCSW provider, sliding adjustment for Medicare cost-sharing), and follow-up in 2 weeks for medication tolerability and 4 weeks for early response assessment. The practice's care coordinator schedules the follow-up and connects the beneficiary with bereavement support resources.

The encounter is billed as AWV (G0439 subsequent AWV) plus G0444 with modifier 25 (separately identifiable depression screening with extensive assessment beyond the AWV element). Cost-sharing is $0 for both services under the ACA Section 4104 waiver. Follow-up E/M visits for medication management and psychotherapy sessions are subject to standard Part B cost-sharing, covered substantially by the beneficiary's Medicare Supplement Plan G.

Example 2: Worth County Age 75 Male Negative PHQ-2 Annual Screening at FQHC

A 75-year-old man living in Worth County (rural southwest Georgia), enrolled in Original Medicare Part B, comes to a Federally Qualified Health Center for his annual primary care visit. The FQHC has an integrated behavioral health workflow with a behavioral health consultant available on-site three days per week. The medical assistant administers PHQ-2 as part of the rooming process. The patient scores 1 on PHQ-2 (negative). He reports being generally content, active in his church, walking daily, and connected with his children and grandchildren who live nearby.

The primary care provider documents the negative depression screening and notes the patient's social connectedness as a protective factor. The screening is billed as G0444 with $0 cost-sharing under the ACA Section 4104 waiver. The FQHC's behavioral health consultant infrastructure satisfies the staff-assisted depression care supports requirement of NCD 210.9. The patient is reassessed at his next annual visit 12 months later.

Example 3: Cobb County Positive Screen Behavioral Health Referral to Ridgeview Outpatient Programs

A 68-year-old woman living in Cobb County, enrolled in Medicare Advantage (Wellstar Total Care), comes to her Wellstar primary care practice for her annual visit. The practice's PHQ-9 screening returns a score of 18 (moderately severe depression). She has had increasing depressive symptoms over the past four months following her diagnosis of advanced osteoarthritis with planned hip replacement. The primary care physician initiates duloxetine 30 mg daily (with attention to potential effects on pain symptoms given duloxetine's coverage of both depression and chronic pain), refers to Ridgeview Institute outpatient behavioral health programs for psychotherapy, and schedules follow-up in 2 weeks.

The patient enrolls in an outpatient cognitive behavioral therapy group at Ridgeview, with cost-sharing applied per Wellstar Total Care Medicare Advantage plan benefits. Over 8 weeks of CBT and titration of duloxetine to 60 mg daily, her PHQ-9 score decreases from 18 to 7 (mild). She undergoes hip replacement at week 12 of treatment with continued mental health support. The annual depression screening identified depression that would have likely remained untreated, and the integrated behavioral health pathway produced substantial symptom improvement during a high-risk life transition.

Example 4: DeKalb County Age 78 Male Positive Screen With Suicidal Ideation Crisis Intervention

A 78-year-old non-Hispanic white man living in DeKalb County, enrolled in Original Medicare Part B, comes to his Emory primary care practice for an annual visit. He had been doing well until his wife of 50 years died of pancreatic cancer 3 months earlier. PHQ-9 score is 22 (severe depression). PHQ-9 Question 9 is endorsed at "nearly every day" with the response that "yes, I think about ending my life almost daily." The primary care physician conducts immediate suicide risk assessment: the patient reports daily passive thoughts but also describes recent active thoughts of using his hunting rifle. He has not made specific plans but acknowledges thinking about it "many times each week." He has access to firearms at home.

The primary care physician determines imminent suicide risk and connects the patient with the Georgia Crisis and Access Line (1-800-715-4225) for emergency psychiatric evaluation. The mobile crisis team responds and supports transfer to Peachford Hospital for inpatient psychiatric admission. The patient is admitted to the Senior Care Program at Peachford for stabilization. Treatment during the inpatient stay includes initiation of escitalopram 10 mg daily, removal of firearms from the home (with family member assistance), and intensive psychotherapy. Discharge planning includes step-down to a partial hospitalization program for 4 weeks, transition to outpatient psychiatry, and follow-up with the primary care practice.

The screening encounter is billed as G0444 with $0 cost-sharing. Subsequent inpatient psychiatric admission is covered under Part A with standard cost-sharing per Original Medicare. The case illustrates the life-saving potential of structured annual depression screening for older adults, particularly older men in the highest-risk demographic for late-life suicide.

Example 5: Memory Care Patient Depression Screening Complexity With Dementia at Northeast Georgia Health System

An 82-year-old woman living in Hall County, enrolled in Original Medicare with Georgia Medicaid as secondary payer, has moderate Alzheimer's disease and resides in a memory care assisted living community. She is followed by a Northeast Georgia Health System geriatrics practice. During her annual primary care visit, her geriatrician uses the Cornell Scale for Depression in Dementia (CSDD), a clinician-administered tool that incorporates caregiver input from the memory care nursing staff and clinical observation. The CSDD score is 9, suggesting probable depression.

The geriatrician obtains additional history from the memory care nursing staff describing increased agitation, decreased social engagement, decreased food intake, and tearfulness. The geriatrician initiates sertraline 25 mg daily (with planned slow titration to limit side effects in this medically complex patient) and engages the memory care behavioral support team for non-pharmacologic interventions including increased social activity, music therapy, and structured daily routine. Reassessment in 4 weeks with the CSDD shows improvement to score of 4, consistent with treatment response. The screening is billed as G0444 with documentation of the use of the CSDD as the validated screening tool for this dementia patient. Cost-sharing is $0 for the screening; subsequent E/M visits are covered with Medicare and Medicaid coordination.

Example 6: Bibb County Annual Depression Screening Continuity Patient With Chronic Depression Successfully Managed in Primary Care

A 72-year-old man living in Bibb County (Macon), enrolled in Original Medicare Part B for seven years, has chronic major depressive disorder diagnosed in his late 50s. He has been stable on sertraline 100 mg daily and quarterly maintenance psychotherapy with an LCSW for the past 8 years. He comes to his Atrium Health Navicent primary care practice for his annual visit. The practice's PHQ-9 administration returns a score of 4 (minimal symptoms), consistent with depression in sustained remission.

The primary care physician reviews medication adherence, side effects, and life circumstances. The patient reports stable functioning, active engagement in his church community, regular contact with his adult children, and recent satisfying retirement-era pursuits. The physician continues the current treatment regimen, reassesses in 12 months, and remains available for earlier follow-up if symptoms worsen. The G0444 annual screening provides systematic monitoring of a chronic depression in remission, satisfying both the NCD 210.9 annual screening requirement and the clinical objective of detecting any recurrence. Cost-sharing is $0 under the ACA Section 4104 waiver.

Part 13: Frequently Asked Questions

What is the Medicare Annual Depression Screening benefit?

Medicare covers annual depression screening for adult Medicare beneficiaries through National Coverage Determination (NCD) 210.9, established under Section 1861(ddd) preventive services authority. The benefit became effective October 14, 2011.

Who is eligible?

All Medicare Part B beneficiaries are eligible for annual depression screening. There are no specific demographic or clinical eligibility limitations beyond the requirement that the screening be performed in a primary care setting with staff-assisted depression care supports.

How often can I receive depression screening?

Once per 12-month period. The 12-month interval is calculated from the calendar date of the prior screening, not from a calendar year boundary.

What is the HCPCS code for depression screening?

HCPCS G0444 (annual depression screening, 15 minutes). The 15-minute time element is part of the code definition.

What does the screening cost?

$0. ACA Section 4104 waives Part B cost-sharing for USPSTF Grade B aligned screening. Annual depression screening is free when furnished according to NCD 210.9 requirements.

Where can the screening be performed?

The screening must be performed in a primary care setting that has staff-assisted depression care supports in place. Primary care settings include family medicine, internal medicine, geriatric medicine, FQHCs, RHCs, and similar primary care practices. Emergency departments, inpatient hospital settings, skilled nursing facilities, and other excluded settings cannot bill G0444.

What are staff-assisted depression care supports?

Staff (such as nurses, social workers, case managers, or care coordinators) who can support the primary care clinician in (a) accurate diagnosis, (b) effective treatment, and (c) follow-up. The requirement ensures that depression screening is integrated with depression care.

What screening tools are used?

Common tools include the Patient Health Questionnaire (PHQ-2 for initial screening, PHQ-9 for severity assessment and severity), the Geriatric Depression Scale (GDS-15), and other validated tools. NCD 210.9 does not prescribe specific tools.

What if my screening is positive?

A positive screen triggers further clinical evaluation including diagnostic assessment, suicide risk assessment, discussion of treatment options (pharmacotherapy, psychotherapy, behavioral health integration), and follow-up planning. Treatment is covered under standard Part B and Part D cost-sharing, not under the NCD 210.9 cost-sharing waiver.

How does this relate to the Annual Wellness Visit?

The Annual Wellness Visit (G0438 initial / G0439 subsequent) includes depression screening as a required health risk assessment element. The standalone G0444 can be billed in addition to the AWV when more extensive depression assessment occurs, with appropriate modifier use. Practices vary in their approach.

Does Medicare cover psychotherapy?

Yes. Medicare Part B covers individual, family, and group psychotherapy by qualified mental health providers including psychiatrists, psychologists, clinical social workers, marriage and family therapists (effective 2024), mental health counselors (effective 2024), and certain other provider categories.

Does Medicare cover antidepressant medications?

Yes. Medicare Part D covers antidepressant medications including SSRIs, SNRIs, atypical antidepressants, and other classes. Specific coverage and cost-sharing depend on the beneficiary's Part D plan formulary.

What is the Collaborative Care Model?

The Collaborative Care Model (CoCM) is an evidence-based approach to depression treatment in primary care involving a primary care clinician, a behavioral health care manager, and a psychiatric consultant. Medicare covers CoCM under HCPCS codes G0512 (RHC/FQHC), 99492, 99493, and 99494.

What is the suicide risk for older adults?

Older adults face the highest suicide rates of any age group in the United States, with rates particularly high among older non-Hispanic white men. Approximately 70 percent of older adults who die by suicide had seen their primary care clinician within the prior 30 days, underscoring the importance of primary care depression screening.

What is the 988 Suicide and Crisis Lifeline?

988 is the streamlined three-digit number for the National Suicide and Crisis Lifeline, operational nationally since July 16, 2022. 988 provides 24/7 crisis support replacing the prior 1-800-273-TALK (8255) number.

What is the Georgia Crisis and Access Line?

The Georgia Crisis and Access Line (1-800-715-4225) is operated by the Georgia Department of Behavioral Health and Developmental Disabilities. GCAL provides 24/7 crisis intervention, mobile crisis response, behavioral health information and referral, and care coordination.

Where can I get behavioral health treatment in Georgia?

Major Georgia behavioral health programs include Skyland Trail, Ridgeview Institute, Peachford Hospital, Emory Behavioral Health, Wellstar Behavioral Health, Piedmont Behavioral Health, the network of Community Service Boards, and private psychiatry and psychotherapy practices. FQHCs provide integrated primary care and behavioral health services, particularly important for underserved populations.

What if I live in rural Georgia?

Rural Georgia faces behavioral health workforce shortages. Resources include FQHCs and RHCs with integrated behavioral health, Community Service Boards across all Georgia counties, telebehavioral health (including audio-only services for many indications), and the Collaborative Care Model when implemented by rural primary care practices.

Does Medicare cover telebehavioral health?

Yes. Medicare coverage of telebehavioral health expanded substantially during and after the public health emergency. Audio-only behavioral health services are covered for many indications. Confirm specific telehealth coverage with Palmetto GBA or your Medicare Advantage plan.

What if I'm dually eligible for Medicare and Medicaid?

Dually eligible beneficiaries have Medicaid as secondary payer for Medicare Part B cost-sharing. For depression screening (G0444) cost-sharing is already $0 under the ACA Section 4104 waiver. For downstream care (psychotherapy, medication management, behavioral health integration), Medicaid coverage of Part B cost-sharing depends on plan structure. Georgia Medicaid may have behavioral health carve-out arrangements.

What about depression screening in nursing home residents?

Nursing home residents are not eligible for the G0444 NCD 210.9 benefit because nursing homes are excluded from the primary care setting requirement. Depression assessment in nursing home residents is part of the comprehensive assessment requirements under Section 1819 of the SSA (nursing home reform). Treatment of identified depression is covered under standard Medicare and Medicaid coverage.

What about depression screening during hospital admissions?

Inpatient hospital settings are excluded from the G0444 coverage. Depression assessment during a hospital admission is part of clinical care and is included in the inpatient stay coverage under Part A. Outpatient follow-up after discharge can include depression screening if performed in a primary care setting.

How does Medicare Advantage cover depression screening?

Medicare Advantage plans must cover the annual depression screening benefit at least as comprehensively as Original Medicare. Cost-sharing for the screening is typically $0 in-network. Plans may have specific provider network requirements; confirm with the plan.

Can I see any behavioral health provider?

Original Medicare allows beneficiaries to see any Medicare-enrolled mental health provider. Medicare Advantage plans typically have provider networks; in-network providers will have lower cost-sharing. Coverage of MFTs and MHCs effective January 1, 2024 substantially expanded provider supply.

Where can I get help understanding my Medicare depression screening coverage?

Contact GeorgiaCares SHIP at 1-866-552-4464 for free, unbiased Medicare counseling. You can also call 1-800-MEDICARE or contact Palmetto GBA (the Medicare Administrative Contractor for Georgia) at 1-866-238-9650 with specific claim questions. Mental Health America of Georgia and NAMI Georgia also provide beneficiary education and advocacy.

Resources and Contacts

For questions about the Medicare Annual Depression Screening benefit, behavioral health resources, and crisis intervention in Georgia, the following resources can help:

Medicare: 1-800-MEDICARE (1-800-633-4227). General Medicare benefit questions, eligibility verification, claim status.
Palmetto GBA Medicare Administrative Contractor for Georgia: 1-866-238-9650. Depression screening claim adjudication, coverage clarifications.
Georgia DCH Medicaid Member Services: 1-866-211-0950. Medicaid eligibility for dually eligible beneficiaries, behavioral health carve-out coordination.
GeorgiaCares SHIP: 1-866-552-4464. Free Medicare counseling including depression screening benefit navigation.
Medicare Rights Center: 1-800-333-4114. Beneficiary advocacy and education.
988 Suicide and Crisis Lifeline: 988. 24/7 crisis support nationwide.
Georgia Crisis and Access Line: 1-800-715-4225. 24/7 crisis intervention, mobile crisis, and referral.
Georgia Department of Behavioral Health and Developmental Disabilities: 404-657-2252. State coordination of public behavioral health services.
Atlanta Legal Aid Society: 404-377-0701. Free legal assistance metro Atlanta.
Georgia Legal Services Program: 1-800-498-9469. Free legal assistance outside metro Atlanta.
211 Georgia: 211. Social service navigation.
Eldercare Locator: 1-800-677-1116. Local Area Agency on Aging services.
National Alliance on Mental Illness Georgia: 770-408-0625. Beneficiary and family education and support.
Mental Health America of Georgia: 770-741-1481. Mental health education and advocacy.
SAMHSA National Helpline: 1-800-662-4357. 24/7 confidential treatment referral and information.
Skyland Trail: 404-315-8333. Atlanta intensive outpatient and residential mental health.
Ridgeview Institute: 770-434-4567. Cobb County inpatient and outpatient behavioral health.
Peachford Hospital: 770-455-3200. Atlanta inpatient psychiatric and senior care programs.
Acentra Health Beneficiary and Family Centered Care Quality Improvement Organization: 1-844-455-8708. Quality concerns and appeals.

Annual depression screening is among the most consequential preventive services Medicare covers. Beneficiaries who complete the screening connect with behavioral health treatment when needed. Late-life depression is treatable. Georgia primary care practices integrating depression screening with effective treatment pathways through the staff-assisted depression care supports infrastructure can meaningfully reduce the substantial burden of depression and suicide in the older adult population.